If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 6 of 6
Assessment of Cardiovascular Risk in Inflammatory Bowel Disease Patients
Objective
Cardiovascular Risk in IBD
Protocol No
GI-IIT-SINH-CV-IN-IBD
Categories
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of MK-7240 in Participants with Moderately to Severely Active Ulcerative Colitis
Objective
Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis
Protocol No
GI-MERCK-MK7240-001
Categories
A Phase 2/3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis
Objective
Dupilumab for Eosinophilic Gastritis W WO Eosinophilic Duodenitis
Protocol No
GI-REGENERON-ENGAGE
Categories
Pregnancy in Inflammatory Bowel Disease And Neonatal Outcomes: Long-Term Outcomes of In-Utero Biologic and Thiopurine Exposure (PIANO)
Objective
Pregnancy in Inflammatory Bowel Disease And Neonatal Outcomes (PIANO)
Protocol No
GI-UCSF-PIANO
Categories
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Objective
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Protocol No
GI-YARUR-SPARC
Categories
A Prospective, Single-arm, Multi-center, Open-label Trial Evaluating the Continuous Application of Prevena Therapy for up to 14 Days
Objective
Continuous Treatment With PREVENA Therapy for 14 Days
Protocol No
SURG-3M-PREVENA
Categories